Michael Hafner

Statistics

Publications

Citations

H-Index

Active since

2019

Affiliations

Theravance Biopharma (United States)(Current)

Michael Hafner is an author at Theravance Biopharma (United States) specializing in optimization of drug-like properties, signal transduction, and anti-proliferative signaling.

Publications per year

2019–2025

Publications

Abstract P5-04-07: GDC-9545: A novel ER antagonist and clinical candidate that combines desirable mechanistic and pre-clinical DMPK attributes

Ciara Metcalfe, Ellen Ingalla, RA Blake et al. · Cancer Research · 2019 · 23 citations

Medicine, Oncology, Pharmacology +13

Switching to Faricimab in Therapy-Resistant Macular Edema Due to Retinal Vein Occlusion: Initial Real-World Efficacy Outcomes

Michael Hafner, Tina Herold, Alexander Kufner et al. · Journal of Clinical Medicine · 2025 · 12 citations · Full text

Medicine, Ophthalmology, Pharmacotherapy +16

1–2 of 2